The radiochromic dosimeter PRESAGE® has shown potential in conventional radiotherapies, but it suffers from dose under-responding, or signal quenching, in proton therapy as a result of dependence on variations in the linear energy transfer (LET). Early investigations have shown the under-response is affected by the chemical concentration of the active components, but as yet this relationship has not been comprehensively measured. This study investigated the impact of PRESAGE® formulation changes on signal quenching to determine the magnitude by which the quenching can be minimized.
CITATION STYLE
Carroll, M., Alqathami, M., & Ibbott, G. (2017). The quenching effect in PRESAGE® by a proton beam: Investigation of formulation dependence. In Journal of Physics: Conference Series (Vol. 847). Institute of Physics Publishing. https://doi.org/10.1088/1742-6596/847/1/012027
Mendeley helps you to discover research relevant for your work.